[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
Oura, K., Morishita, A., Tani, J. and Masaki, T. (2021) Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review. International Journal of Molecular Sciences, 22, Article 5801. https://doi.org/10.3390/ijms22115801
|
[3]
|
Chew, V., Lai, L., Pan, L., Lim, C.J., Li, J., Ong, R., et al. (2017) Delineation of an Immunosuppressive Gradient in Hepatocellular Carcinoma Using High-Dimensional Proteomic and Transcriptomic Analyses. Proceedings of the National Academy of Sciences, 114, E5900-E5909. https://doi.org/10.1073/pnas.1706559114
|
[4]
|
Cheng, K., Cai, N., Zhu, J., Yang, X., Liang, H. and Zhang, W. (2022) Tumor‐Associated Macrophages in Liver Cancer: From Mechanisms to Therapy. Cancer Communications, 42, 1112-1140. https://doi.org/10.1002/cac2.12345
|
[5]
|
Peng, C., Xu, Y., Wu, J., Wu, D., Zhou, L. and Xia, X. (2024) TME-Related Biomimetic Strategies against Cancer. International Journal of Nanomedicine, 19, 109-135. https://doi.org/10.2147/ijn.s441135
|
[6]
|
都亚薇, 张宁宁, 陆伟. 肝癌免疫治疗的研究现状及展望[J]. 实用肿瘤杂志, 2021, 36(5): 393-398.
|
[7]
|
Chen, Q., Wang, X. and He, M. (2022) Cell-in-Cell: From Cell Biology to Translational Medicine. BioMed Research International, 2022, Article 7608521. https://doi.org/10.1155/2022/7608521
|
[8]
|
Eberth, J. (1864) Über die feineren bau der darmschleithaut. Würzburger Naturwissenschaftliche Zeitschrift, 5, 11.
|
[9]
|
Steinhaus, J. (1891) Ueber Carcinom-Einschlüsse. (Aus dem Pathologischen Laboratorium der k. Universität zu Warschau.). In: Steinhaus, J., Ed., Band 126, De Gruyter, Boston, 533-541. https://doi.org/10.1515/9783112369142-030
|
[10]
|
Lewis, W.H. (1925) The Engulfment of Living Blood Cells by Others of the Same Type. The Anatomical Record, 31, 43-49. https://doi.org/10.1002/ar.1090310106
|
[11]
|
Humble, J.G., Jayne, W.H.W. and Pulvertaft, R.J.V. (1956) Biological Interaction between Lymphocytes And. Other Cells. British Journal of Haematology, 2, 283-294. https://doi.org/10.1111/j.1365-2141.1956.tb06700.x
|
[12]
|
Overholtzer, M., Mailleux, A.A., Mouneimne, G., Normand, G., Schnitt, S.J., King, R.W., et al. (2007) A Nonapoptotic Cell Death Process, Entosis, That Occurs by Cell-In-Cell Invasion. Cell, 131, 966-979. https://doi.org/10.1016/j.cell.2007.10.040
|
[13]
|
Davies, S.P., Reynolds, G.M., Wilkinson, A.L., Li, X., Rose, R., Leekha, M., et al. (2019) Hepatocytes Delete Regulatory T Cells by Enclysis, a CD4+ T Cell Engulfment Process. Cell Reports, 29, 1610-1620.e4. https://doi.org/10.1016/j.celrep.2019.09.068
|
[14]
|
Lozupone, F. and Fais, S. (2015) Cancer Cell Cannibalism: A Primeval Option to Survive. Current Molecular Medicine, 15, 836-841. https://doi.org/10.2174/1566524015666151026100916
|
[15]
|
Lozupone, F., Perdicchio, M., Brambilla, D., Borghi, M., Meschini, S., Barca, S., et al. (2009) The Human Homologue of Dictyostelium discoideum Phg1A Is Expressed by Human Metastatic Melanoma Cells. EMBO Reports, 10, 1348-1354. https://doi.org/10.1038/embor.2009.236
|
[16]
|
Ruan, B., Niu, Z., Jiang, X., Li, Z., Tai, Y., Huang, H., et al. (2019) High Frequency of Cell-in-Cell Formation in Heterogeneous Human Breast Cancer Tissue in a Patient with Poor Prognosis: A Case Report and Literature Review. Frontiers in Oncology, 9, Article 1444. https://doi.org/10.3389/fonc.2019.01444
|
[17]
|
孙静, 闵婕, 单宇鹏, 等. “cell-in-cell”对胃癌细胞生物学行为的影响[J]. 西部医学, 2022, 34(9): 1272-1275.
|
[18]
|
Davies, S.P., Terry, L.V., Wilkinson, A.L. and Stamataki, Z. (2020) Cell-in-cell Structures in the Liver: A Tale of Four E’s. Frontiers in Immunology, 11, Article 650. https://doi.org/10.3389/fimmu.2020.00650
|
[19]
|
Brown, G.C. and Neher, J.J. (2012) Eaten Alive! Cell Death by Primary Phagocytosis: ‘Phagoptosis’. Trends in Biochemical Sciences, 37, 325-332. https://doi.org/10.1016/j.tibs.2012.05.002
|
[20]
|
Lugini, L., Matarrese, P., Tinari, A., Lozupone, F., Federici, C., Iessi, E., et al. (2006) Cannibalism of Live Lymphocytes by Human Metastatic but Not Primary Melanoma Cells. Cancer Research, 66, 3629-3638. https://doi.org/10.1158/0008-5472.can-05-3204
|
[21]
|
Hinojosa, L.S., Holst, M., Baarlink, C. and Grosse, R. (2017) MRTF Transcription and Ezrin-Dependent Plasma Membrane Blebbing Are Required for Entotic Invasion. Journal of Cell Biology, 216, 3087-3095. https://doi.org/10.1083/jcb.201702010
|
[22]
|
Cunin, P., Bouslama, R., Machlus, K.R., Martínez-Bonet, M., Lee, P.Y., Wactor, A., et al. (2019) Megakaryocyte Emperipolesis Mediates Membrane Transfer from Intracytoplasmic Neutrophils to Platelets. eLife, 8, e44031. https://doi.org/10.7554/elife.44031
|
[23]
|
Wang, S., He, M., Chen, Y., Wang, M., Yu, X., Bai, J., et al. (2013) Rapid Reuptake of Granzyme B Leads to Emperitosis: An Apoptotic Cell-in-Cell Death of Immune Killer Cells Inside Tumor Cells. Cell Death & Disease, 4, e856. https://doi.org/10.1038/cddis.2013.352
|
[24]
|
Bauer, M.F., Hader, M., Hecht, M., Büttner-Herold, M., Fietkau, R. and Distel, L.V.R. (2021) Cell-in-Cell Phenomenon: Leukocyte Engulfment by Non-Tumorigenic Cells and Cancer Cell Lines. BMC Molecular and Cell Biology, 22, Article No. 39. https://doi.org/10.1186/s12860-021-00377-3
|
[25]
|
Benseler, V., Warren, A., Vo, M., Holz, L.E., Tay, S.S., Le Couteur, D.G., et al. (2011) Hepatocyte Entry Leads to Degradation of Autoreactive CD8 T Cells. Proceedings of the National Academy of Sciences, 108, 16735-16740. https://doi.org/10.1073/pnas.1112251108
|
[26]
|
Guyden, J., Martinez, M., Chilukuri, R., Reid, V., Kelly, F. and Samms, M. (2015) Thymic Nurse Cells Participate in Heterotypic Internalization and Repertoire Selection of Immature Thymocytes; Their Removal from the Thymus of Autoimmune Animals May Be Important to Disease Etiology. Current Molecular Medicine, 15, 828-835. https://doi.org/10.2174/1566524015666151026102328
|
[27]
|
Yener, Y. and Dikmenli, M. (2011) The Effects of Acrylamide on the Frequency of Megakaryocytic Emperipolesis and the Mitotic Activity of Rat Bone Marrow Cells. Journal of the Science of Food and Agriculture, 91, 1810-1813. https://doi.org/10.1002/jsfa.4388
|
[28]
|
Mlynarczuk-Bialy, I., Dziuba, I., Sarnecka, A., Platos, E., Kowalczyk, M., Pels, K.K., et al. (2020) Entosis: From Cell Biology to Clinical Cancer Pathology. Cancers, 12, Article 2481. https://doi.org/10.3390/cancers12092481
|
[29]
|
Stratton, M.R., Campbell, P.J. and Futreal, P.A. (2009) The Cancer Genome. Nature, 458, 719-724. https://doi.org/10.1038/nature07943
|
[30]
|
Podlaha, O., Riester, M., De, S. and Michor, F. (2012) Evolution of the Cancer Genome. Trends in Genetics, 28, 155-163. https://doi.org/10.1016/j.tig.2012.01.003
|
[31]
|
Matsushita, H., Vesely, M.D., Koboldt, D.C., Rickert, C.G., Uppaluri, R., Magrini, V.J., et al. (2012) Cancer Exome Analysis Reveals a T-Cell-Dependent Mechanism of Cancer Immunoediting. Nature, 482, 400-404. https://doi.org/10.1038/nature10755
|
[32]
|
Schreiber, R.D., Old, L.J. and Smyth, M.J. (2011) Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion. Science, 331, 1565-1570. https://doi.org/10.1126/science.1203486
|
[33]
|
Zhang, Y. and Zhang, Z. (2020) The History and Advances in Cancer Immunotherapy: Understanding the Characteristics of Tumor-Infiltrating Immune Cells and Their Therapeutic Implications. Cellular & Molecular Immunology, 17, 807-821. https://doi.org/10.1038/s41423-020-0488-6
|
[34]
|
Pardoll, D.M. (2012) The Blockade of Immune Checkpoints in Cancer Immunotherapy. Nature Reviews Cancer, 12, 252-264. https://doi.org/10.1038/nrc3239
|
[35]
|
Chen, L. and Flies, D.B. (2013) Molecular Mechanisms of T Cell Co-Stimulation and Co-Inhibition. Nature Reviews Immunology, 13, 227-242. https://doi.org/10.1038/nri3405
|
[36]
|
Gutwillig, A., Santana-Magal, N., Farhat-Younis, L., Rasoulouniriana, D., Madi, A., Luxenburg, C., et al. (2022) Transient Cell-in-Cell Formation Underlies Tumor Relapse and Resistance to Immunotherapy. eLife, 11, e80315. https://doi.org/10.7554/elife.80315
|
[37]
|
Ferreira, L.M.R., Muller, Y.D., Bluestone, J.A. and Tang, Q. (2019) Next-Generation Regulatory T Cell Therapy. Nature Reviews Drug Discovery, 18, 749-769. https://doi.org/10.1038/s41573-019-0041-4
|
[38]
|
Bluestone, J.A. and Tang, Q. (2018) Treg Cells—The Next Frontier of Cell Therapy. Science, 362, 154-155. https://doi.org/10.1126/science.aau2688
|
[39]
|
Romano, M., Fanelli, G., Albany, C.J., Giganti, G. and Lombardi, G. (2019) Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity. Frontiers in Immunology, 10, Article 43. https://doi.org/10.3389/fimmu.2019.00043
|
[40]
|
Tarao, K., Nozaki, A., Ikeda, T., Sato, A., Komatsu, H., Komatsu, T., et al. (2019) Real Impact of Liver Cirrhosis on the Development of Hepatocellular Carcinoma in Various Liver Diseases—Meta‐Analytic Assessment. Cancer Medicine, 8, 1054-1065. https://doi.org/10.1002/cam4.1998
|
[41]
|
Ramakrishna, G., Rastogi, A., Trehanpati, N., Sen, B., Khosla, R. and Sarin, S.K. (2013) From Cirrhosis to Hepatocellular Carcinoma: New Molecular Insights on Inflammation and Cellular Senescence. Liver Cancer, 2, 367-383. https://doi.org/10.1159/000343852
|
[42]
|
O’Rourke, J.M., Sagar, V.M., Shah, T. and Shetty, S. (2018) Carcinogenesis on the Background of Liver Fibrosis: Implications for the Management of Hepatocellular Cancer. World Journal of Gastroenterology, 24, 4436-4447. https://doi.org/10.3748/wjg.v24.i39.4436
|
[43]
|
Takaki, A. (2015) Control of Oxidative Stress in Hepatocellular Carcinoma: Helpful or Harmful? World Journal of Hepatology, 7, 968-979. https://doi.org/10.4254/wjh.v7.i7.968
|
[44]
|
Pinato, D.J., Guerra, N., Fessas, P., Murphy, R., Mineo, T., Mauri, F.A., et al. (2020) Immune-Based Therapies for Hepatocellular Carcinoma. Oncogene, 39, 3620-3637. https://doi.org/10.1038/s41388-020-1249-9
|
[45]
|
Wang, Y., Ma, Y., Fang, Y., Wu, S., Liu, L., Fu, D., et al. (2012) Regulatory T Cell: A Protection for Tumour Cells. Journal of Cellular and Molecular Medicine, 16, 425-436. https://doi.org/10.1111/j.1582-4934.2011.01437.x
|
[46]
|
Qureshi, O.S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E.M., et al. (2011) Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4. Science, 332, 600-603. https://doi.org/10.1126/science.1202947
|
[47]
|
Budhu, A., Forgues, M., Ye, Q., Jia, H., He, P., Zanetti, K.A., et al. (2006) Prediction of Venous Metastases, Recurrence, and Prognosis in Hepatocellular Carcinoma Based on a Unique Immune Response Signature of the Liver Microenvironment. Cancer Cell, 10, 99-111. https://doi.org/10.1016/j.ccr.2006.06.016
|
[48]
|
Yu, S., Wang, Y., Hou, J., Li, W., Wang, X., Xiang, L., et al. (2020) Tumor-Infiltrating Immune Cells in Hepatocellular Carcinoma: Tregs Is Correlated with Poor Overall Survival. PLOS ONE, 15, e0231003. https://doi.org/10.1371/journal.pone.0231003
|
[49]
|
Zhou, Y., Shao, N., Aierken, N., Xie, C., Ye, R., Qian, X., et al. (2017) Prognostic Value of Tumor-Infiltrating FoxP3+ Regulatory T Cells in Patients with Breast Cancer: A Meta-Analysis. Journal of Cancer, 8, 4098-4105. https://doi.org/10.7150/jca.21030
|
[50]
|
Shang, B., Liu, Y., Jiang, S. and Liu, Y. (2015) Prognostic Value of Tumor-Infiltrating FoxP3+ Regulatory T Cells in Cancers: A Systematic Review and Meta-Analysis. Scientific Reports, 5, Article No. 15179. https://doi.org/10.1038/srep15179
|
[51]
|
Leslie, C., Bowyer, S.E., White, A., Grieu-Iacopetta, F., Trevenen, M., Iacopetta, B., et al. (2015) FOXP3+ T Regulatory Lymphocytes in Primary Melanoma Are Associated with BRAF Mutation but Not with Response to BRAF Inhibitor. Pathology, 47, 557-563. https://doi.org/10.1097/pat.0000000000000314
|
[52]
|
Kurebayashi, Y., Ojima, H., Tsujikawa, H., Kubota, N., Maehara, J., Abe, Y., et al. (2018) Landscape of Immune Microenvironment in Hepatocellular Carcinoma and Its Additional Impact on Histological and Molecular Classification. Hepatology, 68, 1025-1041. https://doi.org/10.1002/hep.29904
|
[53]
|
Davies, S.P., Reynolds, G.M., Wilkinson, A.L., Li, X., Rose, R., Leekha, M., et al. (2019) Hepatocytes Delete Regulatory T Cells by Enclysis, a CD4+ T Cell Engulfment Process. Cell Reports, 29, 1610-1620.E4. https://doi.org/10.1016/j.celrep.2019.09.068
|
[54]
|
Curran, M.A., Montalvo, W., Yagita, H. and Allison, J.P. (2010) PD-1 and CTLA-4 Combination Blockade Expands Infiltrating T Cells and Reduces Regulatory T and Myeloid Cells within B16 Melanoma Tumors. Proceedings of the National Academy of Sciences, 107, 4275-4280. https://doi.org/10.1073/pnas.0915174107
|
[55]
|
Langhans, B., Nischalke, H.D., Krämer, B., Dold, L., Lutz, P., Mohr, R., et al. (2019) Role of Regulatory T Cells and Checkpoint Inhibition in Hepatocellular Carcinoma. Cancer Immunology, Immunotherapy, 68, 2055-2066. https://doi.org/10.1007/s00262-019-02427-4
|
[56]
|
Sangro, B., Gomez-Martin, C., de la Mata, M., Iñarrairaegui, M., Garralda, E., Barrera, P., et al. (2013) A Clinical Trial of CTLA-4 Blockade with Tremelimumab in Patients with Hepatocellular Carcinoma and Chronic Hepatitis C. Journal of Hepatology, 59, 81-88. https://doi.org/10.1016/j.jhep.2013.02.022
|
[57]
|
Sangro, B., Park, J., Dela Cruz, C.M., Anderson, J., Lang, L., Neely, J., et al. (2016) A Randomized, Multicenter, Phase 3 Study of Nivolumab vs Sorafenib as First-Line Treatment in Patients (pts) with Advanced Hepatocellular Carcinoma (HCC): CheckMate-459. Journal of Clinical Oncology, 34, TPS4147. https://doi.org/10.1200/jco.2016.34.15_suppl.tps4147
|
[58]
|
Li, X., Xiang, Y., Li, F., Yin, C., Li, B. and Ke, X. (2019) WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment. Frontiers in Immunology, 10, Article 2293. https://doi.org/10.3389/fimmu.2019.02293
|